| Serial Number | 87232872 |
| Word Mark | REQUILMA |
| Filing Date | Thursday, November 10, 2016 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, February 23, 2024 |
| Registration Number | 5259632 |
| Registration Date | Tuesday, August 8, 2017 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 4, 2017 |
| Goods and Services | Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, February 23, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Novartis AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Basel CH |
| Party Name | Novartis AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Basel CH |
| Party Name | Novartis AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Basel CH |
| Event Date | Event Description |
| Friday, February 23, 2024 | CANCELLED SEC. 8 (6-YR) |
| Monday, August 8, 2022 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Tuesday, August 8, 2017 | REGISTERED-PRINCIPAL REGISTER |
| Friday, June 30, 2017 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
| Tuesday, June 13, 2017 | NOTICE OF ALLOWANCE CANCELLED |
| Friday, June 30, 2017 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, June 13, 2017 | TEAS DELETE 1(B) BASIS RECEIVED |
| Tuesday, May 30, 2017 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, April 4, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 4, 2017 | PUBLISHED FOR OPPOSITION |
| Wednesday, March 15, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 28, 2017 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Tuesday, February 21, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 8, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, February 8, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, January 31, 2017 | ASSIGNED TO LIE |
| Thursday, January 12, 2017 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Thursday, December 29, 2016 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Thursday, December 29, 2016 | LETTER OF SUSPENSION E-MAILED |
| Thursday, December 29, 2016 | SUSPENSION LETTER WRITTEN |
| Tuesday, December 27, 2016 | ASSIGNED TO EXAMINER |
| Wednesday, November 16, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, November 14, 2016 | NEW APPLICATION ENTERED |